ErbB receptor activation is a complex process and is dependent upon the typ
e and number of receptors expressed on a given cell, Previous studies with
defined combinations of ErbB receptors expressed in mammalian cells have he
lped elucidate specific biological responses for many of the recognized gen
e products that serve as ligands for these receptors, However, no study has
examined the binding of these ligands in a defined experimental system. To
address this issue, the relative binding affinities of the egf domains of
eleven ErbB ligands were measured on six ErbB receptor combinations using a
soluble receptor-ligand binding format. The ErbB2/4 heterodimer was shown
to hind all ligands tested with moderate to very high affinity. In contrast
, ErbB3 showed much more restrictive ligand binding specificity and measura
ble binding was observed only with heregulin, neuregulin2 beta, epiregulin
and the synthetic heregulin/egf chimera, biregulin, These studies also reve
aled that ErbB2 preferentially enhances ligand binding to ErbB3 or ErbB4 an
d to a lesser degree to ErbB1. (C) 1999 Federation of European Biochemical
Societies.